Previous 10 | Next 10 |
Anika Therapeutics' share price is being punished by the market owing to some possibly over-ambitious growth projections made in June last year. Management believed it could nearly double revenues, to $230m, by 2024, but after a so-so 2021, these plans have been abandoned. Anika i...
BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate at the Canaccord Genuity Musculoskeletal Conference in Chicago, IL on Tuesd...
Gainers: Sunshine Biopharma (NASDAQ:SBFM) +183%. Bumble (NASDAQ:BMBL) +42%. Bone Biologics (OTCPK:BBLG) +36%. Cano Health (NYSE:CANO) +35%. CPS Technologies (NASDAQ:CPSH) +29%. AST SpaceMobile (NASDAQ:ASTS) +31%. Hudson Technologies (NASDAQ:HDSN) +30%. FIGS (NYSE:FIGS) +30%. Fluent (NASDAQ:FL...
Anika Therapeutics (ANIK -17.1%) stock plummeted following its Q4 results and downgrades by Stephens and Barrington Research. Stephens analyst Chris Cooley downgraded Anika to Equal Weight from Overweight with a price target of $35, down from $50, after the company reported mixed Q4 resu...
Anika Therapeutics, Inc. (ANIK) Q4 2021 Earnings Conference Call March 08, 2022 5:30 PM ET Company Participants Mark Namaroff – Vice President, Investor Relations, ESG and Corporate Communications Cheryl Blanchard – President and Chief Executive Officer Mike Levitz – Exec...
Anika Therapeutics press release (NASDAQ:ANIK): Q4 Non-GAAP EPS of -$0.23 misses by $0.02. Revenue of $35.82M (+9.6% Y/Y) beats by $3.77M. For further details see: Anika Therapeutics Non-GAAP EPS of -$0.23 misses by $0.02, revenue of $35.82M beats by $3.77M
Fourth quarter revenue growth of 10% year-over-year despite COVID headwinds Full-year 2021 revenue up 13% driven by strong growth in Joint Preservation and Restoration BEDFORD, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global ...
ABM, ADES, ANIK, AQST, ATER, AXDX, BEST, BKEP, BMBL, CASY, CDMO, CIVI, CRCT, CTSO, DADA, EVOK, FIGS, FLL, FLNT, FTEK, GLRE, GWRE, HDSN, MDB, MNTS, OTRK, PRSO, SFIX, SNCR, SND, SUMO, WTI, YEXT For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable...
BEDFORD, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its fourth quarter and year-end 2021 financial results after the close of the...
BEDFORD, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on December 1, 2021, Anika granted non-statutory stock options covering an aggregate of 1,069 shares...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
2024-05-19 04:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MONTREAL, May 16, 2024 /CNW/ - Pendopharm, a division of Pharmascience Canada ("Pendopharm"), is pleased to announce the renewal of its exc...
2024-05-09 04:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...